Suzuki T - Search Results

1

Duration of Infectious Virus Shedding by SARS-CoV-2 Omicron Variant-Infected Vaccinees.

Takahashi K, Ishikane M, Ujiie M, Iwamoto N, Okumura N, Sato T, Nagashima M, Moriya A, Suzuki M, Hojo M, Kanno T, Saito S, Miyamoto S, Ainai A, Tobiume M, Arashiro T, Fujimoto T, Saito T, Yamato M, Suzuki T, Ohmagari N. Takahashi K, et al. Among authors: suzuki m, suzuki t. Emerg Infect Dis. 2022 May;28(5):998-1001. doi: 10.3201/eid2805.220197. Epub 2022 Mar 15. Emerg Infect Dis. 2022. PMID: 35290176 Free PMC article.

2

Mucosal IgA responses in influenza virus infections; thoughts for vaccine design.

van Riet E, Ainai A, Suzuki T, Hasegawa H. van Riet E, et al. Among authors: suzuki t. Vaccine. 2012 Aug 31;30(40):5893-900. doi: 10.1016/j.vaccine.2012.04.109. Epub 2012 Jul 24. Vaccine. 2012. PMID: 22835738 Review.

3

Combatting infectious diseases; nanotechnology as a platform for rational vaccine design.

van Riet E, Ainai A, Suzuki T, Kersten G, Hasegawa H. van Riet E, et al. Among authors: suzuki t. Adv Drug Deliv Rev. 2014 Jul;74:28-34. doi: 10.1016/j.addr.2014.05.011. Epub 2014 May 23. Adv Drug Deliv Rev. 2014. PMID: 24862579 Review.

4

Adenovirus Type 7 Pneumonia in Children Who Died from Measles-Associated Pneumonia, Hanoi, Vietnam, 2014.

Hai le T, Thach HN, Tuan TA, Nam DH, Dien TM, Sato Y, Kumasaka T, Suzuki T, Hanaoka N, Fujimoto T, Katano H, Hasegawa H, Kawachi S, Nakajima N. Hai le T, et al. Among authors: suzuki t. Emerg Infect Dis. 2016 Apr;22(4):687-90. doi: 10.3201/eid2204.151595. Emerg Infect Dis. 2016. PMID: 26926035 Free PMC article.

5

Intranasal Inactivated Influenza Vaccines: a Reasonable Approach to Improve the Efficacy of Influenza Vaccine?

Tamura S, Ainai A, Suzuki T, Kurata T, Hasegawa H. Tamura S, et al. Among authors: suzuki t. Jpn J Infect Dis. 2016;69(3):165-79. doi: 10.7883/yoken.JJID.2015.560. Jpn J Infect Dis. 2016. PMID: 27212584 Free article. Review.

6

Intranasal Administration of Whole Inactivated Influenza Virus Vaccine as a Promising Influenza Vaccine Candidate.

Ainai A, Suzuki T, Tamura SI, Hasegawa H. Ainai A, et al. Among authors: suzuki t. Viral Immunol. 2017 Jul/Aug;30(6):451-462. doi: 10.1089/vim.2017.0022. Epub 2017 Jun 26. Viral Immunol. 2017. PMID: 28650274 Review.

7

Functional and structural characteristics of secretory IgA antibodies elicited by mucosal vaccines against influenza virus.

Suzuki T, Ainai A, Hasegawa H. Suzuki T, et al. Vaccine. 2017 Sep 18;35(39):5297-5302. doi: 10.1016/j.vaccine.2017.07.093. Epub 2017 Aug 7. Vaccine. 2017. PMID: 28780981 Review.

8

The road to a more effective influenza vaccine: Up to date studies and future prospects.

Sano K, Ainai A, Suzuki T, Hasegawa H. Sano K, et al. Among authors: suzuki t. Vaccine. 2017 Sep 25;35(40):5388-5395. doi: 10.1016/j.vaccine.2017.08.034. Epub 2017 Aug 31. Vaccine. 2017. PMID: 28866292 Review.

9

Application of HTLV-1 tax transgenic mice for therapeutic intervention.

Hasegawa H, Sano K, Ainai A, Suzuki T. Hasegawa H, et al. Among authors: suzuki t. Adv Biol Regul. 2018 May;68:10-12. doi: 10.1016/j.jbior.2018.02.004. Epub 2018 Feb 13. Adv Biol Regul. 2018. PMID: 29588208 Review.

10

Intranasal inactivated influenza vaccines for the prevention of seasonal influenza epidemics.

Sano K, Ainai A, Suzuki T, Hasegawa H. Sano K, et al. Among authors: suzuki t. Expert Rev Vaccines. 2018 Aug;17(8):687-696. doi: 10.1080/14760584.2018.1507743. Epub 2018 Aug 27. Expert Rev Vaccines. 2018. PMID: 30092690 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

22,365 results

Search Page

Filters